Home › Oncodesign Biotechnology And Bristol-Myers Squibb Enter Into Strategic Drug Discovery Collaboration
 

Keywords :   


Oncodesign Biotechnology And Bristol-Myers Squibb Enter Into Strategic Drug Discovery Collaboration

2016-01-06 06:00:34| drugdiscoveryonline Home Page

ONCODESIGN (Alternext – ALONC), a biotechnology company serving the pharmaceutical industry in the discovery of new therapeutic molecules to fight cancer and other serious illnesses with no known effective treatment, recently announced that it has entered into a strategic collaboration agreement with Bristol-Myers Squibb Company to discover, develop and commercialize novel macrocyclic compounds

Tags: enter drug collaboration strategic

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05Dabbagh Named General Manager of Waldencast Ventures Glaze Brand
20.05BT scraps digital landline switch deadline
20.05Essie Introduces Nail Art Studio
20.05Ilia Beauty Introduces Vegan Lip Sketch Hydrating Crayon
20.05Summer interest rate cut possible, says Bank deputy
20.05Eastern North Pacific Tropical Weather Outlook
20.05Atlantic Tropical Weather Outlook
20.05Farm Progress America, May 20, 2024
More »